Connection

Lisa Ng to Humans

This is a "connection" page, showing publications Lisa Ng has written about Humans.
Connection Strength

0.212
  1. Understanding Molecular Pathogenesis with Chikungunya Virus Research Tools. Curr Top Microbiol Immunol. 2022; 435:33-53.
    View in: PubMed
    Score: 0.008
  2. Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2. EMBO Mol Med. 2021 06 07; 13(6):e14045.
    View in: PubMed
    Score: 0.008
  3. A promiscuous interaction of SARS-CoV-2 with bacterial products. J Mol Cell Biol. 2020 11 18; 12(12):914-915.
    View in: PubMed
    Score: 0.007
  4. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun. 2020 10 16; 11(1):5243.
    View in: PubMed
    Score: 0.007
  5. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020 08 29; 396(10251):603-611.
    View in: PubMed
    Score: 0.007
  6. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity. EBioMedicine. 2020 Aug; 58:102911.
    View in: PubMed
    Score: 0.007
  7. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020 06 01; 11(1):2806.
    View in: PubMed
    Score: 0.007
  8. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 06; 20(6):363-374.
    View in: PubMed
    Score: 0.007
  9. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control. Front Immunol. 2020; 11:879.
    View in: PubMed
    Score: 0.007
  10. Coronaviruses in animals and humans. BMJ. 2020 02 19; 368:m634.
    View in: PubMed
    Score: 0.007
  11. Multimodal assessments of Zika virus immune pathophysiological responses in marmosets. Sci Rep. 2018 11 20; 8(1):17125.
    View in: PubMed
    Score: 0.006
  12. Plasmodium co-infection protects against chikungunya virus-induced pathologies. Nat Commun. 2018 09 25; 9(1):3905.
    View in: PubMed
    Score: 0.006
  13. The 2016 Singapore Zika virus outbreak did not cause a surge in Guillain-Barré syndrome. J Peripher Nerv Syst. 2018 09; 23(3):197-201.
    View in: PubMed
    Score: 0.006
  14. Viperin Poisons Viral Replication. Cell Host Microbe. 2018 08 08; 24(2):181-183.
    View in: PubMed
    Score: 0.006
  15. Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus-Infected Patients. J Infect Dis. 2018 07 24; 218(5):814-824.
    View in: PubMed
    Score: 0.006
  16. Mosquito Saliva Reshapes Alphavirus Infection and Immunopathogenesis. J Virol. 2018 06 15; 92(12).
    View in: PubMed
    Score: 0.006
  17. Zika Virus Infection Preferentially Counterbalances Human Peripheral Monocyte and/or NK Cell Activity. mSphere. 2018 Mar-Apr; 3(2).
    View in: PubMed
    Score: 0.006
  18. Zika virus: from an obscurity to a priority. Microbes Infect. 2018 12; 20(11-12):635-645.
    View in: PubMed
    Score: 0.006
  19. Nonstructural Proteins of Alphavirus-Potential Targets for Drug Development. Viruses. 2018 02 09; 10(2).
    View in: PubMed
    Score: 0.006
  20. Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity. Sci Rep. 2018 01 30; 8(1):1860.
    View in: PubMed
    Score: 0.006
  21. Age has a role in driving host immunopathological response to alphavirus infection. Immunology. 2017 12; 152(4):545-555.
    View in: PubMed
    Score: 0.006
  22. A Sensitive Method for Detecting Zika Virus Antigen in Patients' Whole-Blood Specimens as an Alternative Diagnostic Approach. J Infect Dis. 2017 07 15; 216(2):182-190.
    View in: PubMed
    Score: 0.006
  23. Immunopathology of Chikungunya Virus Infection: Lessons Learned from Patients and Animal Models. Annu Rev Virol. 2017 09 29; 4(1):413-427.
    View in: PubMed
    Score: 0.006
  24. Zika Virus Infects Human Fetal Brain Microglia and Induces Inflammation. Clin Infect Dis. 2017 Apr 01; 64(7):914-920.
    View in: PubMed
    Score: 0.006
  25. Severity of Plasma Leakage Is Associated With High Levels of Interferon ?-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection. J Infect Dis. 2017 Jan 01; 215(1):42-51.
    View in: PubMed
    Score: 0.006
  26. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis. 2012 Apr 01; 205(7):1147-54.
    View in: PubMed
    Score: 0.004
  27. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect Dis. 2006 Mar 02; 6:40.
    View in: PubMed
    Score: 0.003
  28. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection. BMC Infect Dis. 2004 Sep 09; 4:34.
    View in: PubMed
    Score: 0.002
  29. Detection of severe acute respiratory syndrome coronavirus in blood of infected patients. J Clin Microbiol. 2004 Jan; 42(1):347-50.
    View in: PubMed
    Score: 0.002
  30. Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis. 2021 11 02; 73(9):e2932-e2942.
    View in: PubMed
    Score: 0.002
  31. Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir. Front Immunol. 2021; 12:680188.
    View in: PubMed
    Score: 0.002
  32. A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients. STAR Protoc. 2021 09 17; 2(3):100671.
    View in: PubMed
    Score: 0.002
  33. The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study. Eur Heart J Cardiovasc Pharmacother. 2021 05 23; 7(3):e48-e51.
    View in: PubMed
    Score: 0.002
  34. Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study. EBioMedicine. 2021 Apr; 66:103319.
    View in: PubMed
    Score: 0.002
  35. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021 03 23; 10.
    View in: PubMed
    Score: 0.002
  36. COVID-19 vaccines and kidney disease. Nat Rev Nephrol. 2021 05; 17(5):291-293.
    View in: PubMed
    Score: 0.002
  37. Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19. Cell Rep Med. 2021 02 16; 2(2):100193.
    View in: PubMed
    Score: 0.002
  38. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021 01; 17(1):46-64.
    View in: PubMed
    Score: 0.002
  39. Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection. Viruses. 2018 05 17; 10(5).
    View in: PubMed
    Score: 0.002
  40. Efficient detection of Zika virus RNA in patients' blood from the 2016 outbreak in Campinas, Brazil. Sci Rep. 2018 03 05; 8(1):4012.
    View in: PubMed
    Score: 0.002
  41. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice. FASEB J. 2018 07; 32(7):3792-3802.
    View in: PubMed
    Score: 0.002
  42. Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. ACS Infect Dis. 2018 04 13; 4(4):605-619.
    View in: PubMed
    Score: 0.002
  43. Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria. Cell Microbiol. 2018 05; 20(5):e12819.
    View in: PubMed
    Score: 0.002
  44. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population. PLoS Negl Trop Dis. 2017 12; 11(12):e0006163.
    View in: PubMed
    Score: 0.001
  45. Persistence of Zika virus in conjunctival fluid of convalescence patients. Sci Rep. 2017 09 11; 7(1):11194.
    View in: PubMed
    Score: 0.001
  46. Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation. Nat Microbiol. 2017 Oct; 2(10):1435-1445.
    View in: PubMed
    Score: 0.001
  47. Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus-Infected Patients in Brazil. J Infect Dis. 2017 07 15; 216(2):172-181.
    View in: PubMed
    Score: 0.001
  48. Structural Optimizations of Thieno[3,2-b]pyrrole Derivatives for the Development of Metabolically Stable Inhibitors of Chikungunya Virus. J Med Chem. 2017 04 13; 60(7):3165-3186.
    View in: PubMed
    Score: 0.001
  49. Clinical features of patients with Zika and dengue virus co-infection in Singapore. J Infect. 2017 06; 74(6):611-615.
    View in: PubMed
    Score: 0.001
  50. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017 04; 17(4):e107-e117.
    View in: PubMed
    Score: 0.001
  51. Protein kinases C as potential host targets for the inhibition of chikungunya virus replication. Antiviral Res. 2017 Mar; 139:79-87.
    View in: PubMed
    Score: 0.001
  52. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS One. 2009 Nov 17; 4(11):e7870.
    View in: PubMed
    Score: 0.001
  53. SARS transmission pattern in Singapore reassessed by viral sequence variation analysis. PLoS Med. 2005 Feb; 2(2):e43.
    View in: PubMed
    Score: 0.001
  54. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 2003 May 24; 361(9371):1779-85.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.